Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for nonoxynol root_Validation_@count in root_Validation_@count (approximate match)

Showing 181 - 190 of 261 results

First page
Previous page
Next page
Next page

PHOMA EXIGUA VAR. EXIGUA

8JAG41IE4M

Status:

US Approved Allergenic Extract (1965)

Source:

BLA103753

(1965)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5f15c12a-8df0-41de-9d59-7de47e5e89ca

First approved in 1941

Source:

BLA103888

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e627272e-0c9c-444c-9277-8644c27e54fb

Class:

STRUCTURALLY DIVERSE

EGG YOLK

4IPS17B70T

Status:

US Approved Allergenic Extract (1941)

Source:

BLA103888

(1941)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2235beb8-cf43-4f3c-8e02-598b54283f04

First marketed in 1921

Source:

Fresh Egg Yolk N.F.

Source URL:

https://www.gutenberg.org/files/41778/41778-h/41778-h.htm

Class:

STRUCTURALLY DIVERSE

NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN

5JT3N61JSP

Status:

Possibly Marketed Outside US

Source:

NCT03694405: Phase 4 Interventional Completed Meningococcal Disease, Invasive

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03694405

First approved in 2010

Source:

BLA125300

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2dc730d5-55fd-4e98-8c8a-daa7d8f872b0

Class:

STRUCTURALLY DIVERSE

NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN

3O44U6XYQK

Status:

Possibly Marketed Outside US

Source:

NCT03694405: Phase 4 Interventional Completed Meningococcal Disease, Invasive

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03694405

First approved in 2010

Source:

BLA125300

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2dc730d5-55fd-4e98-8c8a-daa7d8f872b0

Class:

STRUCTURALLY DIVERSE

NEISSERIA MENINGITIDIS GROUP Y CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN

2W566Z2PEJ

Status:

Possibly Marketed Outside US

Source:

NCT03694405: Phase 4 Interventional Completed Meningococcal Disease, Invasive

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03694405

First approved in 2010

Source:

BLA125300

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2dc730d5-55fd-4e98-8c8a-daa7d8f872b0

Class:

STRUCTURALLY DIVERSE

NEISSERIA MENINGITIDIS GROUP C CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN

H2W22AGF1P

Status:

Possibly Marketed Outside US

Source:

NCT03694405: Phase 4 Interventional Completed Meningococcal Disease, Invasive

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03694405

First approved in 2010

Source:

BLA125300

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2dc730d5-55fd-4e98-8c8a-daa7d8f872b0

Class:

STRUCTURALLY DIVERSE

JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED)

DZ854I04ZE

Status:

Possibly Marketed Outside US

Source:

NCT02532569: Phase 4 Interventional Completed Japanese Encephalitis

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02532569

First approved in 2009

Source:

BLA125280

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=276b84fb-096b-3f91-e054-00144ff8d46c

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

MHG4XW7BIG

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2007)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

First approved in 2007

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bebf60e5-254d-4f84-8380-071908524ebd

Class:

STRUCTURALLY DIVERSE

HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN

236YGP181O

Status:

Possibly Marketed Outside US

Source:

NCT02542462: Phase 4 Interventional Completed Intussusception

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02542462

First approved in 2006

Source:

BLA125122

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aaf3b24e-85fd-43ee-b657-2ee4df312ec3

Class:

STRUCTURALLY DIVERSE

HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN

25VC15141Q

Status:

Possibly Marketed Outside US

Source:

NCT02542462: Phase 4 Interventional Completed Intussusception

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02542462

First approved in 2006

Source:

BLA125122

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aaf3b24e-85fd-43ee-b657-2ee4df312ec3

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

PHOMA EXIGUA VAR. EXIGUA

Structurally Diverse

EGG YOLK

Structurally Diverse

NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN

Structurally Diverse

NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN

Structurally Diverse

NEISSERIA MENINGITIDIS GROUP Y CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN

Structurally Diverse

NEISSERIA MENINGITIDIS GROUP C CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN

Structurally Diverse

JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN

Structurally Diverse

HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN

Showing 181 - 190 of 261 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1